UnitedHealth Group Inc (UNH) Holdings Reduced by Monument Capital Management

Monument Capital Management reduced its stake in UnitedHealth Group Inc (NYSE:UNH) by 32.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,103 shares of the healthcare conglomerate’s stock after selling 2,967 shares during the period. UnitedHealth Group accounts for about 1.4% of Monument Capital Management’s holdings, making the stock its 19th biggest position. Monument Capital Management’s holdings in UnitedHealth Group were worth $1,624,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently made changes to their positions in UNH. Argent Trust Co grew its position in shares of UnitedHealth Group by 8.3% during the fourth quarter. Argent Trust Co now owns 13,911 shares of the healthcare conglomerate’s stock worth $3,066,000 after acquiring an additional 1,061 shares during the last quarter. Muhlenkamp & Co. Inc. grew its position in shares of UnitedHealth Group by 1.3% during the first quarter. Muhlenkamp & Co. Inc. now owns 58,491 shares of the healthcare conglomerate’s stock worth $12,517,000 after acquiring an additional 731 shares during the last quarter. First Allied Advisory Services Inc. grew its position in shares of UnitedHealth Group by 2.2% during the first quarter. First Allied Advisory Services Inc. now owns 15,232 shares of the healthcare conglomerate’s stock worth $3,257,000 after acquiring an additional 333 shares during the last quarter. Stelac Advisory Services LLC purchased a new position in shares of UnitedHealth Group during the first quarter worth approximately $163,000. Finally, GWM Advisors LLC grew its position in shares of UnitedHealth Group by 9.6% during the first quarter. GWM Advisors LLC now owns 10,186 shares of the healthcare conglomerate’s stock worth $2,212,000 after acquiring an additional 889 shares during the last quarter. Institutional investors own 85.35% of the company’s stock.

In other UnitedHealth Group news, CEO Steven H. Nelson sold 8,142 shares of the firm’s stock in a transaction on Thursday, September 13th. The stock was sold at an average price of $265.00, for a total value of $2,157,630.00. Following the completion of the sale, the chief executive officer now owns 22,496 shares of the company’s stock, valued at $5,961,440. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP D Ellen Wilson sold 15,393 shares of the firm’s stock in a transaction on Friday, August 24th. The shares were sold at an average price of $264.29, for a total value of $4,068,215.97. Following the completion of the sale, the executive vice president now directly owns 66,402 shares of the company’s stock, valued at approximately $17,549,384.58. The disclosure for this sale can be found here. In the last three months, insiders sold 94,745 shares of company stock valued at $24,995,290. 0.87% of the stock is owned by corporate insiders.

Shares of NYSE UNH opened at $259.61 on Friday. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.75 and a quick ratio of 0.75. UnitedHealth Group Inc has a 1-year low of $186.00 and a 1-year high of $272.07. The firm has a market cap of $256.06 billion, a P/E ratio of 25.78, a P/E/G ratio of 1.58 and a beta of 0.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 17th. The healthcare conglomerate reported $3.14 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $3.04 by $0.10. UnitedHealth Group had a return on equity of 22.79% and a net margin of 5.55%. The firm had revenue of $56.09 billion during the quarter, compared to the consensus estimate of $56.10 billion. During the same period last year, the company earned $2.46 earnings per share. The company’s revenue for the quarter was up 12.1% on a year-over-year basis. On average, sell-side analysts predict that UnitedHealth Group Inc will post 12.72 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 18th. Shareholders of record on Friday, September 7th were issued a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 1.39%. The ex-dividend date was Thursday, September 6th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 35.75%.

A number of brokerages have recently issued reports on UNH. Leerink Swann restated an “outperform” rating on shares of UnitedHealth Group in a research report on Wednesday, July 18th. Raymond James raised their target price on shares of UnitedHealth Group from $285.00 to $304.00 and gave the stock a “strong-buy” rating in a research report on Monday, September 24th. ValuEngine lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 11th. Citigroup lowered shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and set a $288.00 target price on the stock. in a research report on Monday, September 10th. Finally, Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $287.00 target price on the stock in a research report on Sunday, July 15th. One research analyst has rated the stock with a hold rating, twenty-two have assigned a buy rating and one has issued a strong buy rating to the company. UnitedHealth Group has an average rating of “Buy” and a consensus price target of $278.61.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

See Also: Trading Strategy Methods for Individual Investors

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply